Biocon Undertakes Bonus Issue Of 2:1 & Recommends Dividend


The biopharmaceutical player Biocon Ltd.,has recommended issue of bonus shares in the proportion of 2:1 i.e. 2 bonus equity shares of Rs 5 each for every 1 fully paid up equity share, each held on record date.

The record date for reckoning eligible shareholders, entitled to receive bonus shares, will be informed to the respective stock exchanges.

The estimated date is within 2 months from the date of the meeting, held on April 27, 2017 to June 26, 2017.

The company has also recommended a final dividend of Rs 3 per equity share of face value of Rs 5 per share (pre-bonus issue) for the financial year ended on March 31, 2017.

Biocon Limited is a biopharmaceutical company, focusing on reducing therapy costs of chronic diseases like autoimmune, diabetes and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe.


For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: